Aging is a complex process of organism decline in physiological functions. There is no clear theory explaining this phenomenon, but the most accepted one is the oxidative stress theory of aging. Biomarkers of oxidative stress, substances, which are formed during oxidative damage of phospholipids, proteins, and nucleic acids, are present in body fluids of diseased people as well as the healthy ones (in a physiological concentration). 8-iso prostaglandin F2α is the most prominent biomarker of phospholipid oxidative damage, o-tyrosine, 3-chlorotyrosine, and 3-nitrotyrosine are biomarkers of protein oxidative damage, and 8-hydroxy-2(')-deoxyguanosine and 8-hydroxyguanosine are biomarkers of oxidative damage of nucleic acids. It is thought that the concentration of biomarkers increases as the age of people increases. However, the concentration of biomarkers in body fluids is very low and, therefore, it is necessary to use a sensitive analytical method. A combination of HPLC and MS was chosen to determine biomarker concentration in three groups of healthy people of a different age (twenty, forty, and sixty years) in order to find a difference among the groups.

Department of Occupational Medicine 1st Faculty of Medicine Charles University Prague and General University Hospital Prague Na Bojisti 1 120 00 Prague 2 Czech Republic

Institute of Chemical Technology Technicka 5 166 28 Prague 6 Czech Republic

Zobrazit více v PubMed

Mandavilli BS, Santos JH, Van Houten B. Mitochondrial DNA repair and aging. Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis. 2002;509(1-2):127–151. PubMed

Block G, Dietrich M, Norkus EP, Packer L. Oxidative stress in human’s populations. In: Cutler RG, Rodriguez H, editors. Critical Reviews of Oxidative Stress and Aging: Advances in Basic Science, Diagnostic and Interventions. Singapore: World Scientific Publishing; 2003. pp. 870–880.

Muller FL, Lustgarten MS, Jang Y, Richardson A, Van Remmen H. Trends in oxidative aging theories. Free Radical Biology and Medicine. 2007;43(4):477–503. PubMed

Harman D. Aging: a theory based on free radical and radiation chemistry. Journal of Gerontology. 1956;11(3):298–300. PubMed

Harman D. The biologic clock: the mitochondria? Journal of the American Geriatrics Society. 1972;20(4):145–147. PubMed

Stadtman ER. Role of oxidant species in aging. Current Medicinal Chemistry. 2004;11(9):1105–1112. PubMed

Sies H. Oxidative Stress. London, UK: Academic Press; 1985. Introductory remarks; pp. 1–8.

Montuschi P, Mondino C, Koch P, Ciabattoni G, Barnes PJ, Baviera G. Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma. Chest. 2007;132(6):1876–1881. PubMed

Tsang KW, Ip SK, Leung R, et al. Exhaled nitric oxide: the effects of age, gender and body size. Lung. 2001;179(2):83–91. PubMed

Montuschi P. Measurement of biomarkers of oxidative stress and airway inflammation in exhaled breath condensate: methodology and potential applications in patients with COPD and healthy smokers. In: Amann A, Smith D, editors. Volatile Biomarkers. chapter 19. Boston, Mass, USA: Elsevier; 2013. pp. 360–381.

Asami S, Manabe H, Miyake J, et al. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung. Carcinogenesis. 1997;18(9):1763–1766. PubMed

Malerba M, Montuschi P. Non-invasive biomarkers of lung inflammation in smoking subjects. Current Medicinal Chemistry. 2012;19(2):187–196. PubMed

Laumbach RJ, Kipen HM. Acute effects of motor vehicle traffic-related air pollution exposures on measures of oxidative stress in human airways. Annals of the New York Academy of Sciences. 2010;1203:107–112. PubMed PMC

Green PS, Mendez AJ, Jacob JS, et al. Neuronal expression of myeloperoxidase is increased in Alzheimer’s disease. Journal of Neurochemistry. 2004;90(3):724–733. PubMed

Hensley K, Maidt ML, Yu Z, Sang H, Markesbery WR, Floyd RA. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. Journal of Neuroscience. 1998;18(20):8126–8132. PubMed PMC

Tohgi H, Abe T, Yamazaki K, Murata T, Ishizaki E, Isobe C. Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer’s disease. Neuroscience Letters. 1999;269(1):52–54. PubMed

Ahmed N, Ahmed U, Thornalley PJ, Hager K, Fleischer G, Münch G. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer’s disease and link to cognitive impairment. Journal of Neurochemistry. 2005;92(2):255–263. PubMed

Nunomura A, Perry G, Pappolla MA, et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer’s disease. Journal of Neuroscience. 1999;19(6):1959–1964. PubMed PMC

Abe T, Tohgi H, Isobe C, Murata T, Sato C. Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer’s disease. Journal of Neuroscience Research. 2002;70(3):447–450. PubMed

Pemberton PW, Ahmad Y, Bodill H, et al. Biomarkers of oxidant stress, insulin sensitivity and endothelial activation in rheumatoid arthritis: a cross-sectional study of their association with accelerated atherosclerosis. BMC Research Notes. 2009;2, article 83 PubMed PMC

Khan F, Siddiqui AA. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus. Clinica Chimica Acta. 2006;370(1-2):100–107. PubMed

Kaur H, Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Letters. 1994;350(1):9–12. PubMed

Hajizadeh S, DeGroot J, TeKoppele JM, Tarkowski A, Collins LV. Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis. Arthritis research & therapy. 2003;5(5):R234–R240. PubMed PMC

Rall LC, Roubenoff R, Meydani SN, Han SN, Meydani M. Urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG) as a marker of oxidative stress in rheumatoid arthritis and aging: effect of progressive resistance training. Journal of Nutritional Biochemistry. 2000;11(11-12):581–584. PubMed

Hazen SL, Heinecke JW. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. Journal of Clinical Investigation. 1997;99(9):2075–2081. PubMed PMC

Sucu N, Ünlü A, Tamer L, et al. 3-Nitrotyrosine in atherosclerotic blood vessels. Clinical Chemistry and Laboratory Medicine. 2003;41(1):23–25. PubMed

Jaruga P, Rozalski R, Jawien A, Migdalski A, Olinski R, Dizdaroglu M. DNA damage products (5′ R)- and (5′ S)-8,5′-cyclo-2′-deoxyadenosines as potential biomarkers in human urine for atherosclerosis. Biochemistry. 2012;51(9):1822–1824. PubMed

Wang B, Zhu H, Sun H, Pan J, Yuan Z, Yu R. Plasma 8-isoprostane concentrations in patients with age-related cataracts. Clinical Chemistry. 2005;51(8):1541–1544. PubMed

Molnár GA, Nemes V, Biró Z, Ludány A, Wagner Z, Wittmann I. Accumulation of the hydroxyl free radical markers meta-, ortho-tyrosine and DOPA in cataractous lenses is accompanied by a lower protein and phenylalanine content of the water-soluble phase. Free Radical Research. 2005;39(12):1359–1366. PubMed

Ates O, Alp HH, Kocer I, Baykal O, Salman IA. Oxidative DNA damage in patients with cataract. Acta Ophthalmologica. 2010;88(8):891–895. PubMed

Rodrigo R, Prat H, Passalacqua W, Araya J, Bächler JP. Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension. Clinical Science. 2008;114(9-10):625–634. PubMed

Hozawa A, Ebihara S, Ohmori K, et al. Increased plasma 8-isoprostane levels in hypertensive subjects: the Tsurugaya project. Hypertension Research. 2004;27(8):557–561. PubMed

Bowers R, Cool C, Murphy RC, et al. Oxidative stress in severe pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine. 2004;169(6):764–769. PubMed

Subash P, Gurumurthy P, Sarasabharathi A, Cherian KM. Urinary 8-OHdG: a marker of oxidative stress to DNA and total antioxidant status in essential hypertension with South Indian population. Indian Journal of Clinical Biochemistry. 2010;25(2):127–132. PubMed PMC

Baek KH, Oh KW, Lee WY, et al. Association of oxidative stress with postmenopausal osteoporosis and the effects of hydrogen peroxide on osteoclast formation in human bone marrow cell cultures. Calcified tissue international. 2010;87(3):226–235. PubMed

Nobécourt E, Jacqueminet S, Hansel B, et al. Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia. Diabetologia. 2005;48(3):529–538. PubMed

Moussavi N, Renier G, Roussin A, Mamputu J-C, Buithieu J, Serri O. Lack of concordance between plasma markers of cardiovascular risk and intima-media thickness in patients with type 2 diabetes. Diabetes, Obesity and Metabolism. 2004;6(1):69–77. PubMed

Nakanishi S, Suzuki G, Kusunoki Y, Yamane K, Egusa G, Kohno N. Increasing of oxidative stress from mitochondria. Diabetes/Metabolism Research and Reviews. 2004;20(5):399–404. PubMed

Molnár GA, Wagner Z, Markó L, et al. Urinary ortho-tyrosine excretion in diabetes mellitus and renal failure: evidence for hydroxyl radical production. Kidney International. 2005;68(5):2281–2287. PubMed

Morrow JD, Roberts LJ., II The isoprostanes: current knowledge and directions for future research. Biochemical Pharmacology. 1996;51(1):1–9. PubMed

Berezan DJ, Dunn KMJ, Falck JR, Davidge ST. Aging increases cytochrome P450 4A modulation of α1-adrenergic vasoconstriction in mesenteric arteries. Journal of Cardiovascular Pharmacology. 2008;51(3):327–330. PubMed

Mohiuddin I, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system. Journal of Surgical Research. 2006;133(2):143–149. PubMed

Morrow JD, Minton TA, Roberts LJ., II The F2-isoprostane, 8-epi-prostaglandin F2α, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins. 1992;44(2):155–163. PubMed

Elmhurst JL, Betti P-A, Rangachari PK. Intestinal effects of isoprostanes: evidence for the involvement of prostanoid EP and TP receptors. Journal of Pharmacology and Experimental Therapeutics. 1997;282(3):1198–1205. PubMed

Kromer BM, Tippins JR. Coronary artery constriction by the isoprostane 8-epi prostaglandin F(2α) British Journal of Pharmacology. 1996;119(6):1276–1280. PubMed PMC

Tesar V, Zima T. Isoprostany—nove markery a mediatory oxidacniho stresu. Remedia. 1999;9(5):308–316.

Montuschi P, Collins JV, Ciabattoni G, et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. American Journal of Respiratory and Critical Care Medicine. 2000;162(3):1175–1177. PubMed

Kostikas K, Koutsokera A, Papiris S, Gourgoulianis KI, Loukides S. Exhaled breath condensate in patients with asthma: implications for application in clinical practice. Clinical and Experimental Allergy. 2008;38(4):557–565. PubMed

Montuschi P, Barnes PJ. Isoprostanes and asthma. Drug Discovery Today: Therapeutic Strategies. 2006;3(3):287–292.

Shanle EK, Xu W. Selectively targeting estrogen receptors for cancer treatment. Advanced Drug Delivery Reviews. 2010;62(13):1265–1276. PubMed PMC

Gupta A, Saha P, Descôteaux C, Leblanc V, Asselin É, Bérubé G. Design, synthesis and biological evaluation of estradiol-chlorambucil hybrids as anticancer agents. Bioorganic and Medicinal Chemistry Letters. 2010;20(5):1614–1618. PubMed

Van Themsche C, Parent S, Leblanc V, et al. VP-128, a novel oestradiol-platinum(II) hybrid with selective anti-tumour activity towards hormone-dependent breast cancer cells in vivo. Endocrine-Related Cancer. 2009;16(4):1185–1195. PubMed

Descôteaux C, Brasseur K, Leblanc V, Parent S, Asselin É, Bérubé G. SAR study of tyrosine-chlorambucil hybrid regioisomers; Synthesis and biological evaluation against breast cancer cell lines. Amino Acids. 2012;43(2):923–935. PubMed

Harrison JE, Schultz J. Studies on the chlorinating activity of myeloperoxidase. Journal of Biological Chemistry. 1976;251(5):1371–1374. PubMed

Klebanoff SJ. Myeloperoxidase: friend and foe. Journal of Leukocyte Biology. 2005;77(5):598–625. PubMed

Kontush A, Chapman MJ. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacological Reviews. 2006;58(3):342–374. PubMed

Oram JF, Heinecke JW. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiological Reviews. 2005;85(4):1343–1372. PubMed

Passarelli M, Tang C, McDonald TO, et al. Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal from cells. Diabetes. 2005;54(7):2198–2205. PubMed

Fitzgerald ML, Morris AL, Chroni A, Mendez AJ, Zannis VI, Freeman MW. ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux. Journal of Lipid Research. 2004;45(2):287–294. PubMed

Wang N, Silver DL, Costet P, Tall AR. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. Journal of Biological Chemistry. 2000;275(42):33053–33058. PubMed

Hassan HH, Denis M, Lee D-YD, et al. Identification of an ABCA1-dependent phospholipid-rich plasma membrane apolipoprotein A-I binding site for nascent HDL formation: implications for current models of HDL biogenesis. Journal of Lipid Research. 2007;48(11):2428–2442. PubMed

Vaughan AM, Tang C, Oram JF. ABCA1 mutants reveal an interdependency between lipid export function, apoA-I binding activity, and Janus kinase 2 activation. Journal of Lipid Research. 2009;50(2):285–292. PubMed PMC

Vedhachalam C, Duong PT, Nickel M, et al. Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles. Journal of Biological Chemistry. 2007;282(34):25123–25130. PubMed

Vedhachalam C, Ghering AB, Davidson WS, Lund-Katz S, Rothblat GH, Phillips MC. ABCA1-induced cell surface binding sites for ApoA-I. Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27(7):1603–1609. PubMed

Shao B, Tang C, Heinecke JW, Oram JF. Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export. Journal of Lipid Research. 2010;51(7):1849–1858. PubMed PMC

Mu H, Wang X, Lin PH, Yao Q, Chen C. Chlorotyrosine promotes human aortic smooth muscle cell migration through increasing superoxide anion production and ERK1/2 activation. Atherosclerosis. 2008;201(1):67–75. PubMed PMC

Creighton TE. Proteins: Structures and Molecular Properties. 2nd edition. New York, NY, USA: Freeman W.H. and Company; 1993.

Souza JM, Choi I, Chen Q, et al. Proteolytic degradation of tyrosine nitrated proteins. Archives of Biochemistry and Biophysics. 2000;380(2):360–366. PubMed

Savvides SN, Scheiwein M, Böhme CC, et al. Crystal structure of the antioxidant enzyme glutathione reductase inactivated by peroxynitrite. Journal of Biological Chemistry. 2002;277(4):2779–2784. PubMed

Souza JM, Daikhin E, Yudkoff M, Raman CS, Ischiropoulos H. Factors determining the selectivity of protein tyrosine nitration. Archives of Biochemistry and Biophysics. 1999;371(2):169–178. PubMed

Souza JM, Peluffo G, Radi R. Protein tyrosine nitration-functional alteration or just a biomarker? Free Radical Biology and Medicine. 2008;45(4):357–366. PubMed

Macmillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proceedings of the National Academy of Sciences of the United States of America. 1996;93(21):11853–11858. PubMed PMC

Zou M, Martin C, Ullrich V. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biological Chemistry. 1997;378(7):707–713. PubMed

Cassina AM, Hodara R, Souza JM, et al. Cytochrome c nitration by peroxynitrite. Journal of Biological Chemistry. 2000;275(28):21409–21415. PubMed

Batthyány C, Souza JM, Durán R, Cassina A, Cerveñansky C, Radi R. Time course and site(s) of cytochrome c tyrosine nitration by peroxynitrite. Biochemistry. 2005;44(22):8038–8046. PubMed

Vadseth C, Souza JM, Thomson L, et al. Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species. Journal of Biological Chemistry. 2004;279(10):8820–8826. PubMed

Balafanova Z, Bolli R, Zhang J, et al. Nitric oxide (NO) induces nitration of protein kinase Cε (PKCε), facilitating PKCε translocation via enhanced PKCε-RACK2 interactions. A novel mechanism of no-triggered activation of PKCε . Journal of Biological Chemistry. 2002;277(17):15021–15027. PubMed

Souza JM, Castro L, Cassina AM, Batthyány C, Radi R. Nitrocytochrome c: synthesis, Purification, and Functional Studies. Methods in Enzymology. 2008;441:197–215. PubMed

Francescutti D, Baldwin J, Lee L, Mutus B. Peroxynitrite modification of glutathione reductase: modeling studies and kinetic evidence suggest the modification of tyrosines at the glutathione disulfide binding site. Protein Engineering. 1996;9(2):189–194. PubMed

Pehar M, Vargas MR, Robinson KM, et al. Peroxynitrite transforms nerve growth factor into an apoptotic factor for motor neurons. Free Radical Biology and Medicine. 2006;41(11):1632–1644. PubMed

Blanchard-Fillion B, Souza JM, Friel T, et al. Nitration and inactivation of tyrosine hydroxylase by peroxynitrite. Journal of Biological Chemistry. 2001;276(49):46017–46023. PubMed

Knapp LT, Kanterewicz BI, Hayes EL, Klann E. Peroxynitrite-induced tyrosine nitration and inhibition of protein kinase C. Biochemical and Biophysical Research Communications. 2001;286(4):764–770. PubMed

Skvarilová M, Bulava A, Stejskal D, Adamovská S, Bartek J. Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome. Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia. 2005;149(1):83–87. PubMed

Alagozlua H, Gorgulb A, Bilgihanc A, Tuncerb C, Unalb S. Increased plasma levels of advanced oxidation protein products (AOPP) as a marker for oxidative stress in patients with active ulcerative colitis. Clinics and Research in Hepatology and Gastroenterology. 2013;37:80–85. PubMed

Kasai H, Kawai K, Li Y. Analysis of 8-OH-dG and 8-OH-Gua as biomarkers of oxidative stress. Genes and Environment. 2008;30(2):33–40.

Malayappan B, Garrett TJ, Segal M, Leeuwenburgh C. Urinary analysis of 8-oxoguanine, 8-oxoguanosine, fapy-guanine and 8-oxo-2′-deoxyguanosine by high-performance liquid chromatography-electrospray tandem mass spectrometry as a measure of oxidative stress. Journal of Chromatography A. 2007;1167(1):54–62. PubMed

Hayakawa H, Sekiguchi M. Human polynucleotide phosphorylase protein in response to oxidative stress. Biochemistry. 2006;45(21):6749–6755. PubMed

Shan X, Tashiro H, Lin C-LG. The identification and characterization of oxidized RNAs in Alzheimer’s disease. Journal of Neuroscience. 2003;23(12):4913–4921. PubMed PMC

Shan X, Chang Y, Lin C-LG. Messenger RNA oxidation is an early event preceding cell death and causes reduced protein expression. FASEB Journal. 2007;21(11):2753–2764. PubMed

Choi S, Choi H-H, Lee S-H, et al. Anti-inflammatory effects of 8-hydroxy-2′-deoxyguanosine on lipopolysaccharide-induced inflammation via Rac suppression in Balb/c mice. Free Radical Biology and Medicine. 2007;43(12):1594–1603. PubMed

Irie M, Tamae K, Iwamoto-Tanaka N, Kasai H. Occupational and lifestyle factors and urinary 8-hydroxydeoxyguanosine. Cancer Science. 2005;96(9):600–606. PubMed PMC

Montuschi P, Varone F, Valente S. Methodological aspects of exhaled prostanoids measurements. European Respiratory Journal. 2003;22(45, article 18s)

Montuschi P, Ragazzoni E, Valente S, et al. Validation of 8-isoprostane and prostaglandin E2 measurements in exhaled breath condensate. Inflammation Research. 2003;52(12):502–507. PubMed

Baraldi E, Ghiro L, Piovan V, et al. Increased exhaled 8-isoprostane in childhood asthma. Chest. 2003;124(1):25–31. PubMed

Carpenter CT, Price PV, Christman BW. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest. 1998;114(6):1653–1659. PubMed

Ohashi N, Yoshikawa M. Rapid and sensitive quantification of 8-isoprostaglandin F(2α) in human plasma and urine by liquid chromatography-electrospray ionization mass spectrometry. Journal of Chromatography B: Biomedical Sciences and Applications. 2000;746(1):17–24. PubMed

Syslova K, Kacer P, Kuzma M, et al. Determination of 8-iso-prostaglandin F(2 alpha) in exhaled breath condensate using combination of immunoseparation and LC-ESI-MS/MS. Journal of Chromatography B. 2008;867(1):8–14. PubMed

Pennathur S, Jackson-Lewis V, Przedborski S, Heinecke JW. Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o′-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson’s disease. Journal of Biological Chemistry. 1999;274(49):34621–34628. PubMed

Leeuwenburgh C, Rasmussen JE, Hsu FF, Mueller DM, Pennathur S, Heinecke JW. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. Journal of Biological Chemistry. 1997;272(6):3520–3526. PubMed

Matayatsuk C, Poljak A, Bustamante S, et al. Quantitative determination of ortho- and meta-tyrosine as biomarkers of protein oxidative damage in β-thalassemia. Redox Report. 2007;12(5):219–228. PubMed

Orhan H, Vermeulen NPE, Tump C, Zappey H, Meerman JHN. Simultaneous determination of tyrosine, phenylalanine and deoxyguanosine oxidation products by liquid chromatography-tandem mass spectrometry as non-invasive biomarkers for oxidative damage. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 2004;799(2):245–254. PubMed

Syslová K, Kačer P, Kuzma M, et al. LC-ESI-MS/MS method for oxidative stress multimarker screening in the exhaled breath condensate of asbestosis/silicosis patients. Journal of Breath Research. 2010;4(1)017104 PubMed

Cheng M-L, Chen C-M, Gu P-W, Ho H-Y, Chiu DT-Y. Elevated levels of myeloperoxidase, white blood cell count and 3-chlorotyrosine in Taiwanese patients with acute myocardial infarction. Clinical Biochemistry. 2008;41(7-8):554–560. PubMed

Sentürker S, Karahalil B, Inal M, Yilmaz H, Gedikoglu G, Dizdaroglu M. Oxidative DNA base damage and antioxidant enzyme levels in childhood acute lymphoblastic leukemia. FEBS Letters. 1997;416(3):286–290. PubMed

Barreto M, Villa MP, Olita C, Martella S, Ciabattoni G, Montuschi P. 8-Isoprostane in exhaled breath condensate and exercise-induced bronchoconstriction in asthmatic children and adolescents. Chest. 2009;135(1):66–73. PubMed

Lucidi V, Ciabattoni G, Bella S, Barnes PJ, Montuschi P. Exhaled 8-isoprostane and prostaglandin E2 in patients with stable and unstable cystic fibrosis{star, open} Free Radical Biology and Medicine. 2008;45(6):913–919. PubMed

Gumieniczek A, Owczarek B, Pawlikowska B. Oxidative/nitrosative stress and protein damages in aqueous humor of hyperglycemic rabbits: effects of two oral antidiabetics, pioglitazone and repaglinide. Experimental Diabetes Research. 2012;2012:6 pages.653678 PubMed PMC

Di Domenico F, Coccia R, Butterfield DA, Perluigi M. Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limits. Biochimica et Biophysica Acta: Proteins and Proteomics. 2011;1814(12):1785–1795. PubMed

Sultana R, Butterfield DA. Identification of the oxidative stress proteome in the brain. Free Radical Biology and Medicine. 2011;50(4):487–494. PubMed PMC

Butterfield DA, Perluigi M, Sultana R. Oxidative stress in Alzheimer’s disease brain: new insights from redox proteomics. European Journal of Pharmacology. 2006;545(1):39–50. PubMed

Montuschi P, Mores N, Trové A, Mondino C, Barnes PJ. The electronic nose in respiratory medicine. Respiration. 2013;85(1):72–84. PubMed

Bofan M, Mores N, Baron M, et al. Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD. Journal of Breath Research. 2013;7(1)017103 PubMed

De Laurentiis G, Paris D, Melck D, et al. Separating smoking-related diseases using NMR-based metabolomics of exhaled breath condensate. Journal of Proteome Research. 2013;12(3):1502–1511. PubMed

Motta A, Paris D, Melck D, et al. Nuclear magnetic resonance-based metabolomics of exhaled breath condensate: methodological aspects. European Respiratory Journal. 2012;39(2):498–500. PubMed

Montuschi P, Paris D, Melck D, et al. NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis. Thorax. 2012;67(3):222–228. PubMed

Wheelock CE, Goss VM, Balgoma D, et al. Application of ’omics technologies to biomarker discovery in inflammatory lung diseases. European Respiratory Journal. 2013;42(3):802–825. PubMed

Söderling A-S, Ryberg H, Gabrielsson A, et al. A derivatization assay using gaschromatography/negative chemical ionization tandem mass spectrometry to quantify 3-nitrotyrosine in human plasma. Journal of Mass Spectrometry. 2003;38(11):1187–1196. PubMed

Schwedhelm E, Tsikas D, Gutzki F-M, Frölich JC. Gas chromatographic-tandem mass spectrometric quantification of free 3-nitrotyrosine in human plasma at the basal state. Analytical Biochemistry. 1999;276(2):195–203. PubMed

Tsikas D, Schwedhelm E, Stutzer FK, et al. Accurate quantification of basal plasma levels of 3-nitrotyrosine and 3-nitrotyrosinoalbumin by gas chromatography-tandem mass spectrometry. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 2003;784(1):77–90. PubMed

Jiang H, Balazy M. Detection of 3-nitrotyrosine in human platelets exposed to peroxynitrite by a new gas chromatography/mass spectrometry assay. Nitric Oxide: Biology and Chemistry. 1998;2(5):350–359. PubMed

Pietzsch J, Bergmann R, Kopprasch S. Analysis of non-protein amino acids as specific markers of low density lipoprotein apolipoprotein B-100 oxidation in human atherosclerotic lesions: the use of N(O)-ethoxycarbonyl trifluoroethyl ester derivatives and GC-MS. Spectroscopy. 2004;18(2):177–183.

Jacob KD, Noren Hooten N, Trzeciak AR, Evans MK. Markers of oxidant stress that are clinically relevant in aging and age-related disease. Mechanisms of Ageing and Development. 2013;134(3-4):139–157. PubMed PMC

Siomek A, Gackowski D, Rozalski R, et al. Higher leukocyte 8-oxo-7,8-dihydro-2′-deoxyguanosine and lower plasma ascorbate in aging humans? Antioxidants and Redox Signaling. 2007;9(1):143–150. PubMed

Montine TJ, Peskind ER, Quinn JF, Wilson AM, Montine KS, Galasko D. Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer’s disease as identified by biomarkers. NeuroMolecular Medicine. 2011;13(1):37–43. PubMed PMC

Three-Year Study of Markers of Oxidative Stress in Exhaled Breath Condensate in Workers Producing Nanocomposites, Extended by Plasma and Urine Analysis in Last Two Years

NanoTiO2 Sunscreen Does Not Prevent Systemic Oxidative Stress Caused by UV Radiation and a Minor Amount of NanoTiO2 is Absorbed in Humans

Markers of Oxidative Stress in the Exhaled Breath Condensate of Workers Handling Nanocomposites